Baseline metabolic profiles of early rheumatoid arthritis patients achieving sustained drug-free remission after initiating treat-to-target tocilizumab, methotrexate, or the combination: insights from systems biology

Teitsma, X.M.; Yang, W.; Jacobs, J.W.G.; Petho-Schramm, A.; Borm, M.E.A.; Harms, A.C.; ... ; Lafeber, F.P.J.G. (2018)

Article / Letter to editor

• Rheumatoid arthritis
• Tocilizumab
• Methotrexate
• Drug-free remission
• Metabolomics

• All authors: Teitsma, X.M.; Yang, W.; Jacobs, J.W.G.; Petho-Schramm, A.; Borm, M.E.A.; Harms, A.C.; Hankemeier, T.; Laar, J.M. van; Bijlsma, J.W.J.; Lafeber, F.P.J.G.
• Date: 2018-10-15
• Journal: Arthritis Research & Therapy
• Volume: 20
• Pages: 230
• DOI: doi:10.1186/s13075-018-1729-2